• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Bace: Lead Target for Orchestrated Therapy of Alzheimer's Disease

Bace: Lead Target for Orchestrated Therapy of Alzheimer's Disease

Hardcover

Medical Reference

ISBN10: 047029342X
ISBN13: 9780470293423
Publisher: Wiley
Published: Mar 15 2010
Pages: 266
Weight: 1.10
Height: 0.70 Width: 6.30 Depth: 9.30
Language: English

BACE inhibitors and their use in the treatment of Alzheimer's Disease

BACE (β-site of APP cleaving enzyme) is a critical component in Alzheimer's Disease (AD), and the development of BACE inhibitors shows great potential as a therapy for the disease. BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease covers virtually all aspects of BACE from initial identification, discovery of inhibitors, and challenges in clinical development, while providing a global understanding essential for productive and successful drug discovery.

Also in

Medical Reference